BIOMARIN PHARMACEUTICAL INC Quarterly Return On Equity in % from Q1 2011 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Return On Equity history and growth rate from Q1 2011 to Q3 2024.
  • Biomarin Pharmaceutical Inc Return On Equity for the quarter ending September 30, 2024 was 6.22 %, a 100% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Return On Equity for 2023 was 3.48 %, a 10.8% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Return On Equity for 2022 was 3.14 %.
  • Biomarin Pharmaceutical Inc annual Return On Equity for 2021 was -1.51 %, a 106% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 6.22 +3.12 +100% Jul 1, 2024 Sep 30, 2024
Q2 2024 5.08 +2.93 +136% Apr 1, 2024 Jun 30, 2024
Q1 2024 4.17 +2.61 +167% Jan 1, 2024 Mar 31, 2024
Q4 2023 3.48 +0.34 +10.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 3.1 +1.21 +63.9% Jul 1, 2023 Sep 30, 2023
Q2 2023 2.15 +0.91 +73.3% Apr 1, 2023 Jun 30, 2023
Q1 2023 1.56 +0.65 +70.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 3.14 +4.65 Oct 1, 2022 Dec 31, 2022
Q3 2022 1.89 +1.64 +634% Jul 1, 2022 Sep 30, 2022
Q2 2022 1.24 -18.9 -93.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 0.92 -19.4 -95.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.51 -24.9 -106% Oct 1, 2021 Dec 31, 2021
Q3 2021 0.26 -24.7 -98.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 20.1 +16.3 +421% Apr 1, 2021 Jun 30, 2021
Q1 2021 20.3 +16.6 +452% Jan 1, 2021 Mar 31, 2021
Q4 2020 23.4 +24.1 Oct 1, 2020 Dec 31, 2020
Q3 2020 25 +26.4 Jul 1, 2020 Sep 30, 2020
Q2 2020 3.86 +7.6 Apr 1, 2020 Jun 30, 2020
Q1 2020 3.68 +6.74 Jan 1, 2020 Mar 31, 2020
Q4 2019 -0.79 +1.88 +70.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.42 +2.95 +67.4% Jul 1, 2019 Sep 30, 2019
Q2 2019 -3.74 +0.67 +15.2% Apr 1, 2019 Jun 30, 2019
Q1 2019 -3.06 +2.1 +40.7% Jan 1, 2019 Mar 31, 2019
Q4 2018 -2.67 +1.52 +36.3% Oct 1, 2018 Dec 31, 2018
Q3 2018 -4.38 +1.23 +21.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -4.41 +2.19 +33.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -5.16 +17.2 +76.8% Jan 1, 2018 Mar 31, 2018
Q4 2017 -4.18 +22 +84% Oct 1, 2017 Dec 31, 2017
Q3 2017 -5.61 +14.7 +72.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -6.61 +17 +72% Apr 1, 2017 Jun 30, 2017
Q1 2017 -22.3 -14.3 -178% Jan 1, 2017 Mar 31, 2017
Q4 2016 -26.2 -19 -261% Oct 1, 2016 Dec 31, 2016
Q3 2016 -20.4 -5.93 -41.1% Jul 1, 2016 Sep 30, 2016
Q2 2016 -23.6 -12.7 -117% Apr 1, 2016 Jun 30, 2016
Q1 2016 -8.02 +1.41 +14.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 -7.25 +1.74 +19.3% Oct 1, 2015 Dec 31, 2015
Q3 2015 -14.4 -5.68 -65% Jul 1, 2015 Sep 30, 2015
Q2 2015 -10.8 +2.64 +19.6% Apr 1, 2015 Jun 30, 2015
Q1 2015 -9.44 +3.66 +28% Jan 1, 2015 Mar 31, 2015
Q4 2014 -8.99 +4.77 +34.7% Oct 1, 2014 Dec 31, 2014
Q3 2014 -8.74 +5.2 +37.3% Jul 1, 2014 Sep 30, 2014
Q2 2014 -13.5 -2.93 -27.8% Apr 1, 2014 Jun 30, 2014
Q1 2014 -13.1 -0.93 -7.65% Jan 1, 2014 Mar 31, 2014
Q4 2013 -13.8 -1.74 -14.5% Oct 1, 2013 Dec 31, 2013
Q3 2013 -14 -4.05 -40.9% Jul 1, 2013 Sep 30, 2013
Q2 2013 -10.6 +1.54 +12.7% Apr 1, 2013 Jun 30, 2013
Q1 2013 -12.2 -2.54 -26.4% Jan 1, 2013 Mar 31, 2013
Q4 2012 -12 -4.85 -67.6% Oct 1, 2012 Dec 31, 2012
Q3 2012 -9.89 -4.56 -85.4% Jul 1, 2012 Sep 30, 2012
Q2 2012 -12.1 -40.5 -143% Apr 1, 2012 Jun 30, 2012
Q1 2012 -9.63 -43.2 -129% Jan 1, 2012 Mar 31, 2012
Q4 2011 -7.18 Oct 1, 2011 Dec 31, 2011
Q3 2011 -5.34 Jul 1, 2011 Sep 30, 2011
Q2 2011 28.4 Apr 1, 2011 Jun 30, 2011
Q1 2011 33.6 Jan 1, 2011 Mar 31, 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.